WASHINGTONMutations of the BRCA1 gene occur in a different
region of the gene among black and Hispanic carriers than in whites
and Ash-kenazi Jews, researchers said at the Intercultural Cancer
Councils 7th Biennial Symposium on Minorities, the Medically
Underserved, and Cancer.
BRCA1 mutations in Ashkenazi Jewish women occur most frequently on
exon 2, said Jaydutt Vadgama, PhD, director of the molecular oncology
program, Charles R. Drew University of Medicine and Science, Los
Angeles. The mutation known as 185del AG is predominant in this
group, he said. Another mutation found in Ashkenazis is 5382ins C,
which is also found in non-Ashkenazi whites.
In a study at Drew University, none of 54 black breast cancer
patients or 47 Hispanic breast cancer patients had these mutations,
Dr. Vadgama and co-researcher Dejun Shen, PhD, reported. They did,
however, have mutations on exon 11.
In four black patients, there was a sequence variant labeled A3537G,
and in another black woman, a frameshift mutation identified as
3331ins G was found. A novel mutation identified as C3717T was
discovered in a Hispanic patient.
Several other sequence variants, polymorphism, and frameshift and
nonsense irregularities were revealed as well.
Dr. Vadgama said that further work must be done to identify the
significance of these mutations in relation to incidence and course
of disease. The mutation identified in the Hispanic woman is the
first BRCA1 mutation to be specifically attributed to that ethnic
group. However, it is possible that this mutation and the others seen
in the study might be found in other groups.